Drugs@FDA document
TIMOPTIC-XE Review · NDA 020330 SUPPL-17
Drugs@FDA document · BAUSCH AND LOMB INC · May 8, 2006
Key facts
| Drug name | TIMOPTIC-XE |
|---|---|
| Document type | Review |
| Application | NDA020330 |
| Submission | SUPPL-17 |
| Company | BAUSCH AND LOMB INC |
| Document date | May 8, 2006 |
| FDA document | accessdata.fda.gov |
At a glance
- Medical Review Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: